Senior Vice President of Operations and Clinical Affairs
Jeff D. Prescott, PharmD, RPh
Senior Clinical Projects Manager
Clinical Projects Manager
Michael R. Page, PharmD, RPh
Justin T. Gallagher
Director of Sales
National Account Managers
Chairman and CEO
Mike Hennessy, Sr
Mike Hennessy, Jr
Chief Operating Officer/CFO
Neil Glasser, CPA/CFE
President, Managed Markets, Pharmacy, and Rare Disease
Executive Vice President and General Manager
Chief Creative Officer
Human Resources Director
President, Pharmacy Times Continuing Education
Caroline M. Apovian, MD, FACP, FACN
Nutrition and Weight Management Center
Boston Medical Center
Professor of Medicine and Pediatrics
Boston University School of Medicine
Scott Kahan, MD, MPH
Strategies to Overcome and Prevent (STOP) Obesity Alliance
George Washington University
National Center for Weight and Wellness
Kenneth L. Schaecher, MD, FACP, CPC
Salt Lake City, Utah
Jill E. Allen, PharmD
Drug Information Consultant
Pin Oak Associates
Salt Lake City, Utah
Christine Sokoloski, MS
Hillsborough, New Jersey
Jeannette Y. Wick, RPh, MBA, FASCP
University of Connecticut School of Pharmacy
Caroline M. Apovian, MD, FACP, FACN, has the following relevant financial relationships with commercial interests to disclose:
Amylin, Arena, EnteroMedics, Gelesis, Johnson and Johnson, Merck, Novo Nordisk, Nutrisystem, Orexigen, Sanofi-Aventis, Scientific Intake, Takeda, Zafgen
Amylin, Aspire Bariatrics, the Dr. Robert C. and Veronica Atkins Foundation, GI Dynamics, Lilly, MetaProteomics, MYOS Corporation, Orexigen, Pfizer, Sanofi-Aventis
Science Smart LLC
Scott Kahan, MD, MPH, has the following relevant financial relationships with commercial interests to
American Board of Obesity Medicine
Novo Nordisk, Orexigen, Takeda, Vivus
Kenneth L. Schaecher, MD, FACP, CPC, has no relevant financial relationships with commercial
interests to disclose.
Jill E. Allen, PharmD; Christine Sokoloski, MS; and Jeannette Wick, RPh, MBA, FASCP, have no
relevant financial relationships with commercial interests to disclose.
The American Journal of Managed Care
Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel have no relevant
financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education
Planning Staff—Dave Heckard; Maryjo Dixon, RPh; Dipti Desai, PharmD, RPh; Beatriz Manzor Mitrzyk,
PharmD, BCPS; Donna Fausak; Nathalie Harden; and Tara DeLorenzo have no relevant financial
relationships with commercial interests to disclose.
According to the disclosure policy of The American Journal of Managed Care and Pharmacy Times Continuing Education, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
Disclosure of Unapproved/Off-Label Use
The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and
are advised to consult prescribing information for these products.
The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Continuing Education, or any of the companies that provided commercial support for this CE activity.